| Sep'11 | Jun'11 | Sep'10 | Jun'10 | ||
|---|---|---|---|---|---|
Operating revenues - equipment sales and related services | |||||
260 | 285 | 368 | 274 | ||
Operating revenues - cryobanking and related services | |||||
80 | 73 | 85 | 93 | ||
Total Revenues | |||||
340 | 358 | 453 | 368 | ||
Costs of sales-equipment sales and related services | |||||
136 | 155 | 174 | 156 | ||
Costs of sales-cryobanking and related services | |||||
13 | 5 | 11 | 9 | ||
Total Costs of Sales | |||||
149 | 160 | 185 | 165 | ||
Gross Profit | |||||
191 | 197 | 267 | 202 | ||
Research and development-equipment sales and related services | |||||
591 | 616 | 642 | 687 | ||
Research and development-cryobanking and related services | |||||
46 | 53 | 52 | 47 | ||
Total Research and Development Expenses | |||||
637 | 669 | 694 | 734 | ||
Selling, general, and administrative- equipment sales and related services | |||||
639 | 726 | 651 | 817 | ||
Selling, general and administrative- cryobanking and related services | |||||
175 | 145 | 206 | 155 | ||
Total Selling, General and Administrative Expenses | |||||
815 | 871 | 857 | 973 | ||
Total Operating Expenses | |||||
1,452 | 1,541 | 1,552 | 1,707 | ||
Loss from Operations | |||||
-1,261 | -1,343 | -1,284 | -1,505 | ||
Dividend income-investment portfolio | |||||
645 | 499 | 635 | 518 | ||
Realized gains on sale of securities, net | |||||
253 | 2,279 | 2,370 | 1,489 | ||
Mark to market of short positions | |||||
-6,608 | -1,687 | 2,735 | -318 | ||
Other revenues | |||||
3 | 3 | 3 | 3 | ||
Interest expense | |||||
29 | 81 | 20 | 8 | ||
Administrative expenses relating to portfolio investments | |||||
31 | 37 | 35 | 31 | ||
Total Other (expense) income, net | |||||
-5,767 | 976 | 5,688 | 1,653 | ||
(Loss) Income before income taxes | |||||
-7,028 | -366 | 4,403 | 148 | ||
(Benefit ) provision for income taxes | |||||
-2,845 | -182 | 1,799 | -39 | ||
Net (Loss) Income | |||||
-4,183 | -184 | 2,604 | 188 | ||
Net Income (Loss) | |||||
-4,183 | -184 | 2,604 | 188 | ||
Unrealized (Loss )Gain on Securities Held for Sale, Net of Deferred Income Taxes | |||||
-3,710 | 323 | 3,829 | -3,268 | ||
Comprehensive (Loss) Income | |||||
-7,893 | 139 | 6,434 | -3,080 | ||
Weighted average number of shares outstanding basic and diluted (in Shares) | |||||
4,219 | 4,225 | 4,232 | 4,242 | ||
Net (loss) income per common equivalent share basic and diluted (in Dollars per share) | |||||
-0.99 | -0.04 | 0.62 | 0.04 | ||
Dividends paid per common share (in Dollars per share) | |||||
- | 0.15 | 0.25 | 0.10 | ||